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Summary
Objective: To determine if membrane type-1 matrix metalloproteinase (MT1-MMP) will respond to cyclic compression of chondrocytes grown
in vitro and the regulatory mechanisms underlying this response.
Methods: Cyclic compression (30 min, 1 kPa, 1 Hz) was applied to bovine chondrocytes (6e9-month-old animals) grown on top of a biodegrad-
able substrate within 3 days of initiating culture. Luciferase assays using bovine articular chondrocytes were undertaken to demonstrate the
mechanosensitivity of MT1-MMP. Semi-quantitative reverse-transcription polymerase chain reaction (RT-PCR) and western blot analysis were
used to establish the time course of gene and protein upregulation in response to cyclic compression. The regulation of MT1-MMP was
assessed by electrophoretic mobility shift assays, RT-PCR and western blot analysis. As well, an MT1-MMP decoy oligonucleotide and an
extracellular signal-regulated kinase 1/2 (ERK1/2) pharmacological inhibitor were utilized to further characterize MT1-MMP regulation.
Results: After cyclic compression, MT1-MMP showed a rapid and transient increase in gene expression. Elevated protein levels were de-
tected within 2 h of stimulation which returned to baseline by 6 h. During cyclic compression, phosphorylation of the mitogen activated protein
kinase ERK1/2 increased signiﬁcantly. This was followed by increased gene and protein expression of the transcription factor; early growth
factor-1 (Egr-1) and Egr-1 binding to the MT1-MMP promoter. Blocking Egr-1 DNA binding with a decoy MT1-MMP oligonucleotide, downre-
gulated MT1-MMP gene expression. The ERK1/2 inhibitor U0126 also reduced Egr-1 DNA binding activity to MT1-MMP promoter sequences
and subsequent transcription of MT1-MMP.
Conclusions: These data suggest that cyclic compression of chondrocytes in vitro upregulates MT1-MMP via ERK1/2 dependent activation of
Egr-1 binding. Delineation of the regulatory pathways activated by mechanical stimulation will further our understating of the mechanisms inﬂu-
encing tissue remodeling.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Articular cartilage is a tissue containing specialized cells
(chondrocytes) whose primary function is the production
and maintenance of the extracellular matrix (ECM). This
cartilage is responsible for smooth articulation, load bearing
and transmitting applied forces to the underlying bone1 and
can be damaged as a result of trauma or disease2. Carti-
lage has a limited ability for self-repair in part because it
is avascular1,3. Several biological treatments have been de-
veloped to repair cartilage defects4. Osteochondral transfer
or mosaicplasty is one option and involves transplantation
of osteochondral plugs obtained from donor sites, within
the same joint, into a defect site. The major disadvantages
of this approach are the resulting donor site morbidity and
the difﬁculty in placing the plugs congruent with the joint
surface and to each other. The long-term success of this
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Received 5 December 2006; revision accepted 15 April 2007.130technique is also questionable4. Another treatment option
is perforation (microfracture) of the subchondral bone to
induce cartilage repair. However, this technique results in
ﬁbrocartilage repair that does not have the load bearing
apability of native tissue which degenerates with time5.
Current investigations have focused on developing strate-
gies to replace damaged tissue with tissue engineered
cartilage. One approach to accomplish this is to generate
biphasic constructs by forming cartilage in vitro which is
integrated with the top surface of a porous calcium poly-
phosphate (CPP) substrate that acts as a bone substitute6.
The biphasic construct can then be placed into a joint defect
and anchored in place by lateral integration of the native
tissue to the engineered implant7.
Interestingly, when the chondrocytes grown on these
constructs were exposed to either short- or long-term cyclic
compression in vitro during cartilage formation, this resulted
in tissue with improved physical and mechanical properties
compared to cartilage formed by cells that were not stimu-
lated8,9. We demonstrated previously that a single applica-
tion of cyclic compression of 30 min duration applied early
in culture activated a remodeling process that involved
a series of catabolic and anabolic changes that were1
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there was upregulation of matrix metalloproteinase (MMP)-
13 gene expression by 2 h and protein levels by 6 h
following mechanical stimulation10. This was followed by
increased aggrecan and type II collagen gene expression
by 12 h which resulted in increased proteoglycan and colla-
gen synthesis and accumulation by 24 h after mechanical
stimulation10.
It is not clear why the upregulation of MMP-13 was
delayed and only occurred 2 h post-stimulation. It may be
that there is a preceding event. Although there are several
putative proteases, upregulation of membrane type-1 MMP
(MT1-MMP or MMP-14) is a likely candidate. MT1-MMP
can activate MMP-1311 and has been shown to be mecha-
nosensitive in other cell types as expression of MT1-MMP
increased after application of cyclic strain to rat endothelial
cells12 and after mechanical stretching of human trabecular
meshwork cells in organ cultures13. Furthermore, MT1-
MMP knock-out mice have severe defects in skeletal
development suggesting that this enzyme plays an impor-
tant role in matrix remodeling14,15.
MT1-MMP is a cell surface protease that can degrade
a wide range of ECM molecules and plays a role in pericel-
lular degradation16e18. The mechanisms regulating MT1-
MMP expression in chondrocytes have not been fully
explored. A key regulator of MT1-MMP gene expression
is the zinc-ﬁnger transcription factor, early growth response
protein-1 (Egr-1). Induced by many extracellular molecules
including hormones, neurotransmitters, growth and differen-
tiation factors, and cytotoxic metabolites, Egr-1 is an early
response gene capable of inducing long-term changes
within the cell by altering gene expression of other target
genes19. Binding of Egr-1 (also known as nerve growth
factor induced-A (NGFI-A), krox-24, ZIF268, or TIS8) to
the MT1-MMP promoter region in endothelial cells induces
transcriptional activity20,21. DNA binding activity of Egr-1
to MT1-MMP promoter was shown to increase after cyclic
strain in endothelial cells suggesting that Egr-1 is sensitive
to mechanical stimuli12.
The mitogen activated protein kinase (MAPK) pathway
may be involved in regulating MT1-MMP upregulation in
chondrocytes following mechanical stimulation, as extracel-
lular signal-regulated kinase 1/2 (ERK1/2) appears to regu-
late MT1-MMP expression in the HT1080 ﬁbroblast cell line
after attachment to collagen22 and ERK1/2 activation is
mechanosensitive10. ERK1/2 activation of Egr-1 binding
activity may be a possible regulatory mechanism of MT1-
MMP activation in chondrocytes as phosphorylated ERK
(ERK1/2) has been shown to activate Egr-1 binding in mu-
rine erythroblasts23. To determine if MT1-MMP might play a
role in the catabolic events occurring during matrix remodel-
ing, this study examines whether MT1-MMP is mechano-
sensitive in chondrocytes and to identify the signal
transduction mechanisms regulating its expression under
these conditions.
Methods
ISOLATION OF CELLS
Chondrocytes were obtained from cartilage tissue
harvested from bovine (6e9 months old) metacarpal-
phalangeal joints as described previously24. Brieﬂy, carti-
lage from two to three legs was combined to obtain
sufﬁcient cells for each experiment. Cartilage was digested
for 2 h with 0.5% proteinase in Ham’s F-12 under standard
cell culture conditions (37C, 5% CO2) and incubatedovernight with 0.1% collagenase in Ham’s F-12. The iso-
lated cells were seeded at a density of 160,000 cells/
mm2 in Ham’s F-12 supplemented with 5% fetal bovine
serum (FBS; Sigma Chemical Co., St. Louis, MO) onto
the surfaces of cylindrical discs of CPP surrounded by
Tygon tubing (4.3 mm diameter, Thermoplastics Processor
Inc., San Jose, CA). Porous CPP substrates were pre-
pared as previously described25,26. The CPP constructs
surrounded by Tygon tubing were sterilized by g-irradiation
(2.5 Mrad) prior to cell seeding. The tubing surrounding the
CPP cylinders was used to prevent cell spillage over the
edge of the CPP following seeding. Constructs were main-
tained in Ham’s F-12 supplemented with 5% FBS for 2
days and then serum-starved for 24 h prior to mechanical
stimulation.
MECHANICAL STIMULATION
Within 3 days of seeding, the cells were subjected to uni-
axial, conﬁned cyclic compression of 1 kPa (corresponding
to a strain of 1.4%) using a mechanical stimulator (MACH-1,
Biosyntech, Montreal, Canada) for 30 min at 1 Hz as previ-
ously described9. By 3 days the chondrocytes form a thin
layer of tissue on the top surface of the CPP. The estimated
strain experienced by the tissue was calculated by deter-
mining the difference in displacement of the mechanical
stimulator in the presence or absence of tissue given a con-
stant force of 1 kPa and divided by the tissue height. Since
relatively little matrix accumulates by 3 days and as not to
disperse the chondrocytes during cyclic loading, mechani-
cal stimulation was applied through a compliant 2% agarose
gel cylinder (3.5 mm diameter 8 mm height; approxi-
mately 10 1 kPa compressive stiffness, n¼ 6) (Sigma)
(Fig. 1). The agarose plug-tissue layer construct was then
deformed under displacement control with the amplitude
of cyclic deformation adjusted manually to apply sinusoidal
loading to the construct. Agarose cylinders were removed
immediately after mechanical stimulation. Control samples
Tygon
Tubing
Agarose
Cartilage
Tissue 
CPP
Direction of cyclic
compression applied
to tissue 
Fig. 1. Schematic of biphasic construct with agarose plug. Chondro-
cytes are seeded on the top surface of CPP cylinders surrounded
by a Tygon tubing to prevent cell spillage during seeding. Chondro-
cytes attach and form a thin layer of tissue on top of the CPP by 3
days. An agarose plug is placed onto the construct immediately
prior to application of cyclic compression.
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receive any mechanical stimulation. At the appropriate
time points, samples were harvested and the tissue
removed from the CPP surface. The tissue samples were
either analyzed immediately or frozen at 80C for future
testing.
TRANSFECTION AND LUCIFERASE REPORTER ANALYSIS
Chondrocytes were transfected in suspension (2 106
cells/100 ml serum-free Hams F-12) prior to seeding using
Fugene-6 Transfection reagent (Roche Molecular Biochem-
icals; 6 ml/construct) with 2 mg of either pGL3-Basic promo-
terless luciferase vector, the MT1-MMP(300)-promoter
luciferase construct (genomic promoter fragment extending
from 300 to 39)21, or the MT1-MMP-mutant (m-1)-lucifer-
ase construct (GG to TA mutation in the Egr-1 site located
between 288 and 275)21, in combination with 0.1 mg of
the pRL-SV40 (constitutively active Renilla luciferase plas-
mid) to assess transfection efﬁciency. The DNA/Fugene6
medium was removed after 4 h and the cells seeded on
CPP, grown for 3 days and mechanically stimulated as de-
scribed above. Twenty-four hours after mechanical stimula-
tion, chondrocytes were lysed in 1 Passive Lysis Buffer
(Promega, Madison, WI) and luciferase expression was
measured using the Dual Luciferase Assay System (Prom-
ega), according to the manufacturer’s instructions. Data
were normalized for Renilla luciferase expression, and ex-
pressed as the fold change from luciferase levels of pGL3-
Basic transfected samples.
SEMI-QUANTIFICATION OF GENE EXPRESSION BY REVERSE-
TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR)
To determine the effect of mechanical stimulation on
temporal gene expression, total RNA was extracted from
stimulated and unstimulated tissues at various time points
up to 24 h following mechanical stimulation using Trizol
(Invitrogen, Carlsbad, CA) according to the manufacturer’s
directions27. Total RNA was reverse transcribed (RT) into
cDNA using reverse transcriptase (Superscript II, Invitro-
gen) according to the manufacturer’s instructions. Relative
gene expression was examined by semi-quantitative RT-
PCR using Taq Polymerase (Invitrogen) and sequence-
speciﬁc primers in reactions designed to amplify the
template sequence of interest (Table I). Cycle number ex-
periments were also undertaken for each gene of interest
to ensure that polymerase chain reaction (PCR) products
were within the linear range of ampliﬁcation. Cycling
conditions along with the gene-speciﬁc cycle number are
indicated in Table I. 18S rRNA was the housekeeping
gene against which gene expression was normalized.
PCR products were run on a 1.5%-agarose gel stained
with ethidium bromide. Band intensity was quantiﬁed by
densitometry using Lab Works software (V4.0, Media
Cybernectics).DNA BINDING ACTIVITY
At various time points after mechanical stimulation, the
tissue was excised from the top surface of the CPP and
homogenized in 400 ml of Buffer A (10 mM N-2-hydroxy-
ethylpiperazine-N 0-2-ethanesulfonic acid (HEPES), 10 mM
KCl, 0.1 mM ethylene diamine tetraacetic acid (EDTA),
0.1 mM ethylene glycol tetraacetic acid (EGTA), pH 7.9)
using ﬁve strokes of a type ‘‘B’’ dounce homogenizer. Chon-
drocytes were incubated on ice for 15 min in Buffer A to
allow cells to swell, and lysed using 10% NP-40. Samples
were centrifuged for 1 min at 10,000g at 4C and the super-
natant was removed. The pellet was resuspended and
incubated in 50 ml Buffer C (20 mM HEPES, 0.4 mM NaCl,
1 mM EDTA, 1 mM EGTA, pH 7.9) for 15 min at 4C. The
resultant nuclear extract was clariﬁed through centrifugation
at 10,000g for 10 min at 4C and protein content quantiﬁed
utilizing colorimetric detection with a bicinchoninic acid
(BCA) protein assay kit (Pierce, Rockford, IL).
Nuclear extracts (15 mg) were incubated for 30 min with gel
shift binding buffer (poly (dI-dC), 1 M MgCl2, 0.5 M EDTA,
1 M dithiothreitol (DTT), 5 M NaCl, 1 M TriseHCl (pH 7.5),
0.5 M glycerol) and 32P-labeled double-stranded MT1-MMP
oligonucleotides (50-CATTGGGGCGGGGGCGGAGG-30)
containing the putative Egr-1 and serine protein 1 (Sp1) bind-
ing elements12. Selected samples were also incubated with
either 10-fold excess of unlabeled Egr-1 oligonucleotide,
10-fold excess of unlabeled Sp1 oligonucleotide, or the mu-
tant form of the MT1-MMP promoter oligonucleotide contain-
ing a GG to TA substitution in the Egr-1/Sp1 binding region
(50-GGAGGGCATTGGGGCTAGGGCGGAGG-3, GG to TA
mutation indicated in bold) to conﬁrm the binding speciﬁcity.
Supershift analysis was used to determine if Egr-1 is part of
the DNAeprotein complex. Antibody reactive with Egr-1
(polyclonal, sc-110, Santa Cruz Biotechnology, Santa Cruz,
CA) was pre-incubated with nuclear extracts for 1 h before
the 32P-labeled DNA fragments were added. DNAeprotein
complexes were resolved on a 4% non-denaturing polyacryl-
amide gel containing 5%glycerol and processed for autoradi-
ography by exposing to X-ray ﬁlm (X-OMAT LS, Kodak,
Amersham Biosciences, UK).
WESTERN BLOT ANALYSIS
At various times during and after mechanical stimulation,
the tissue was removed from the CPP and homogenized
with a motorized pestle on ice (400 ml) in a solution of
25 mM 3-(N-Morpholino)-propanesulfonic acid pH 7.4,
50 mM b-glycerophosphate, 2 mM EDTA, 2 mM EGTA,
1 mM Na-orthovanadate, 1 mM NaF and 1 mM DTT with
phenylmethylsulfonyl ﬂuoride added immediately prior to
use. Protein extracts were clariﬁed by centrifugation for
10 min at 10,000g and protein content quantiﬁed utilizing
colorimetric detection with a BCA protein assay kit (Pierce,
Rockford, IL). Proteins from each sample (20 mg) were sep-
arated by sodium-dodecyl-sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) (10% acrylamide, 2 h at 150 V),Table I
PCR primer sequences and cycling conditions
Gene Forward primer
sequence (50e30)
Reverse primer
sequence (50e30)
Annealing
temperature ((C)
Cycle
number
Product
size (bp)
Egr-1 TTGACTTCAGCTGCCTGAAACAGCC ACGGAACAACACTCTGACACATGC 60 30 528
MT1-MMP TCCAGGGACTCAAATGGCAGCATA ATCACATATGTTGGGCCCTGAGGT 60 32 397
18S rRNA AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA 55 28 150
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(BioTrace NT, Pall Life Sciences, Pensacola, FL) then incu-
bated with antibodies reactive with total ERK1/2, phospho-
ERK1/2 (1:1000; Cell Signaling, Beverly, MA), Egr-1
(1:5000; Santa Cruz Biotechnologies), or MT1-MMP
(1:2000; Santa Cruz Biotechnologies) or b-actin (1:5000;
SigmaeAldrich) in tris-buffered saline, 0.1% Tween-20
(10 mM Tris, pH 7.5, 150 mM NaCl, 0.05% v/v Tween-20)
containing 5.0% non-fat dry milk overnight at 4C. To correct
for loading variations, all values were normalized to b-actin.
Immunoreactivity was detected using secondary antibody
conjugated with horseradish peroxidase (1:2000, Cell Signal-
ing) and enhanced chemiluminescence (ECL Plus;
Amersham Biosciences). Each experiment was performed
in triplicate and repeated at least three times. Band intensity
was semi-quantiﬁed by densitometry using Lab Works
software (V4.0, Media Cybernectics). The data were pooled
and the intensities expressed as meanþ S.E.M.
INHIBITION OF Egr-1 DNA BINDING ACTIVITY USING
OLIGONUCLEOTIDE DECOYS (ODN)
Double-stranded oligonucleotides corresponding to the
MT1-MMP promoter sequence used in electrophoretic
mobility shift assays (EMSA) analysis were generated as
decoys for Egr-1 DNA binding activity. ODN undergo
a phosphorothioated modiﬁcation to the four end nucleo-
tides (Operon Biotechnologies, Huntsville, AL). ODN added
directly to cells growing in a three-dimensional (3D) frame-
work will be taken up and block DNA binding activity28. Con-
structs were pre-incubated with ODN (1.0 mM), a mutant
(scrambled) ODN (1.0 mM) or vehicle alone for 4 h prior to
the start of mechanical stimulation in serum-free Ham’s
F-12. The cells were then mechanically stimulated
(30 min, 1 kPa, 1 Hz,) in the presence or absence of the
ODN and compared to cells that were not stimulated but
maintained under similar conditions.
INHIBITION OF ERK1/2 ACTIVATION
To determine the role of the ERK pathway in regulating
MT1-MMP expression by Egr-1 activation the pharmaco-
logical inhibitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis
[2-aminophenylthio]butadiene (Promega)) was used to block
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Fig. 2. Cyclic compression increases Egr-1-dependent trans-
criptional activation of MT1-MMP. Isolated chondrocytes were
transfected with MT1-MMP(300)-luciferase pGL3 or mutant MT1-
MMP-m1 (containing a GG to TA mutation within the Egr-1 binding
site between 288 and 275) reporter constructs prior to seeding
ontoCPP substrates. After 3 days of incubation, sampleswere either
cyclically compressed for 30 min (1 kPa, 1 Hz) in serum-free media
or left unstimulated. RLU was measured 24 h later and normalized
to expression of Renilla luciferase. * indicates a signiﬁcant difference
to unstimulated chondrocytes, P< 0.05.MEK1/2 induced phosphorylation and activation of ERK1/
229. Chondrocytes were pre-incubated in serum-free media
with U0126 (1.0 mM) or vehicle alone for 4 h prior to mechan-
ical stimulation.Unstimulatedandstimulated constructswere
harvested at various times and then processed for western
blot analysis or EMSA as described above.
STATISTICAL ANALYSIS
Each condition was performed in triplicate and all exper-
iments were repeated at least three times. The data were
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Fig. 3. MT1-MMP expression in cyclically compressed chondro-
cytes. Chondrocytes were cyclically compressed for 30 min or left
unstimulated (US) as a control. Total RNA or protein was harvested
from samples during and after mechanical stimulation and semi-
quantiﬁed by RT-PCR analysis or western blot, respectively. 15
indicates the time during mechanical stimulation when the samples
were harvested (at 15 min which is halfway through the period of
cyclic compression). All other samples were harvested at various
times after mechanical stimulation was completed ranging from im-
mediately after (time 0) up to 24 h later. (A) MT1-MMP gene expres-
sion which is expressed as a fold change compared to US controls.
Gene expression was normalized to 18S rRNA. (B) Representative
western blots showing MT1-MMP and b-actin protein expression in
US and stimulated (S) cells over time. b-actin was used to ensure
equal loading of proteins. (C) Fold change in MT1-MMP protein ex-
pression over time in the presence of stimulation as determined by
densitometry. * indicates that the mechanically S sample is signiﬁ-
cantly different from the corresponding US control, P< 0.05.
1305Osteoarthritis and Cartilage Vol. 15, No. 11pooled and expressed as mean S.E.M. Results were eval-
uated using a Student’s t test and statistical signiﬁcance
was assigned at P< 0.05. Differences in gene and protein
expression over time were evaluated using a two-way anal-
ysis of variance (ANOVA) with statistical signiﬁcance as-
signed at P< 0.05.
Results
MT1-MMP EXPRESSION IN CHONDROCYTES
To determine if MT1-MMP is mechanosensitive in chon-
drocytes, cells were transfected with luciferase reporter
plasmids, containing a portion of the MT1-MMP promoter
region with overlapping consensus Egr-1/Sp1 binding sites,
prior to seeding on CPP substrates. After 3 days of culture,
cells were cyclically compressed for 30 min and 24 h later
showed a signiﬁcant (3.9-fold) increase in relative luciferase
activity (RLU) (indicative of MT1-MMP expression) com-
pared to unstimulated controls (Fig. 2). Chondrocytes trans-
fected with the mutant plasmid, containing a scrambled
sequence at the Egr-1/Sp1 binding site, did not show in-
creased luciferase activity conﬁrming the speciﬁcity of the
response.
To establish the time course of this response, MT1-MMP
gene and protein expression were semi-quantiﬁed using
RT-PCR and western blot analysis, respectively, at various
times following cyclic compression. MT1-MMP gene
expression was increased signiﬁcantly by the end of the
period of mechanical stimulation [Fig. 3(A)], remained
elevated 1 h post-stimulation and returned to constitutive
levels by 2 h. Elevated MT1-MMP protein was detected
as early as 1 h post-stimulation and returned to baseline
levels by 6 h post-stimulation [Fig. 3(B)].DNA BINDING ACTIVITY TO THE MT1-MMP PROMOTER
As Egr-1 is a candidate transcription factor that could reg-
ulate MT1-MMP gene expression, Egr-1 DNA binding to
MT1-MMP promoter sequences was assessed by EMSA
using nuclear extracts from unstimulated and stimulated
chondrocytes. There was a transient increase in Egr-1 bind-
ing activity which returned to baseline levels 15 min after
mechanical stimulation ended [Fig. 4(A)]. The speciﬁcity
of binding was conﬁrmed as no increase was detected
when a mutant oligonucleotide (scrambled Egr-1 binding
site) was used or the reaction was done in the presence
of 10-fold excess of unlabeled Egr-1 oligonucleotide probe
[Fig. 4(B)]. Incubation of the nuclear extracts with antibodies
reactive with Egr-1 prior to performing the EMSA resulted in
a supershifted band conﬁrming the presence of Egr-1 in the
proteineDNA complex. Binding activity was only slightly de-
creased by the presence of 10-fold excess of Sp1 oligonu-
cleotide [Fig. 4(B)]. This suggests that mechanical
stimulation promotes binding of the transcription factor
Egr-1 to the MT1-MMP promoter.
MECHANICAL STIMULATION UPREGULATES Egr-1
EXPRESSION
Given that Egr-1 is involved in regulating MT1-MMP gene
levels, the effect of cyclic compression on the expression of
this transcription factor was determined. Within 15 min of
initiating cyclic compression Egr-1 mRNA was upregulated
and remained elevated until 15 min post-stimulation after
which it returned to constitutive levels [Fig. 5(A)]. This cor-
related with increased Egr-1 protein as early as 30 min after
mechanical stimulation. By 1 h Egr-1 protein returned to
constitutive levels but continued to decrease and by 6 hUS S US S S S S 
MT1-MMP 
Mutant MT1-MMP 
Egr-1 competitor (10X)
Sp-1 competitor (10X)
Egr-1 Antibody
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Fig. 4. DNA binding activity at the MT1-MMP promoter. EMSA of nuclear extracts obtained from unstimulated (US) and stimulated (S) chon-
drocytes at (A) various time points post-stimulation or (B) immediately (0 min) after mechanical stimulation in the presence or absence of var-
ious inhibitors. The competitors were used at 10-fold excess (10). EMSA were repeated at least three times. An overexposed EMSA is
shown in (B) to demonstrate the supershift band.
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controls [Fig. 5(B)].
Egr-1 REGULATES MT1-MMP UPREGULATION
To determine if Egr-1 regulated MT1-MMP gene expres-
sion, chondrocytes were cyclically loaded in the presence of
an ODN, which will prevent Egr-1 binding to the MT1-MMP
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Fig. 5. Egr-1 expression in cyclically compressed chondrocytes.
Chondrocytes were cyclically compressed for 30 min and total
RNA or protein harvested. 15 indicates the time during mechani-
cal stimulation when the samples were harvested (at 15 min which
is halfway through the period of cyclic compression). All other sam-
ples were harvested at various times after mechanical stimulation
was completed ranging from immediately after (time 0) up to 24 h
later. Controls were treated identically but were not stimulated
(S). (A) Egr-1 gene expression was normalized to 18S rRNA
gene expression and then expressed as fold change relative to un-
stimulated (US) controls. (B) Representative western blots showing
Egr-1 and b-actin protein levels in US and S cells over time. b-actin
was used to ensure equal loading of proteins. (C) Fold change in
Egr-1 protein expression over time in the presence of stimulation.
Protein expression was semi-quantiﬁed using densitometry and
the data pooled and expressed as mean S.E.M. as described un-
der the Methods section. * indicates that the mechanically S sample
is signiﬁcantly greater than the corresponding US control, P< 0.05.
** indicates that the mechanically S samples are signiﬁcantly lower
than the corresponding US control, P< 0.05.promoter. The presence of the ODN during mechanical
stimulation prevented Egr-1 binding as determined using
EMSA [Fig. 6(A)]. The speciﬁcity of this reaction was con-
ﬁrmed by incubation with a mutant ODN which did not affect
Egr-1 binding to the MT1-MMP promoter [Fig. 6(A)]. Pre-
venting Egr-1 binding through the use of the ODN also pre-
vented the increased MT1-MMP gene expression observed
after cyclic compression [Fig. 6(B)].
CYCLIC COMPRESSION ACTIVATES ERK1/2 WHICH
REGULATES MT1-MMP GENE EXPRESSION
Since ERK1/2 has been shown to be mechanosensitive
and can play a role in regulating Egr-1 expression23,30,
the role of ERK1/2 in regulating MT1-MMP expression in
chondrocytes in response to cyclic compression was exam-
ined. Total ERK1/2 levels did not change over the time in-
vestigated, however, the phosphorylated form of ERK1/2
(p-ERK1/2) increased 13.1-fold within the ﬁrst 15 min of me-
chanical stimulation and although the levels fell they were
still elevated ﬁve-fold at the end of cyclic compression
[Fig. 7(A)].
When cyclic compression was performed in the presence
of the selective pharmocological ERK1/2 inhibitor, U0126,
Egr-1 binding activity to the MT1-MMP promoter was de-
creased in mechanically stimulated cells as determined by
EMSA [Fig. 7(B)]. Interestingly, ERK1/2 inhibition also reg-
ulated constitutive binding activity as the control (unstimu-
lated) cells showed decreased binding in the presence of
U1026. Inhibition of ERK1/2 activation by U1026 prevented
the increase in MT1-MMP gene expression induced by cy-
clic compression [Fig. 7(C)].
Discussion
This study demonstrated that MT1-MMP is mechanosen-
sitive in bovine articular chondrocytes as it is rapidly and
transiently upregulated by a single, short-term (30 min in
duration) application of cyclic compression to chondrocytes
forming cartilage tissue in vitro. The transcriptional regu-
lation of MT1-MMP involved phosphorylation of ERK1/2
followed by an increase in Egr-1 gene and protein expres-
sion and binding to the MT1-MMP promoter. The elevated
DNA binding activity of the Egr-1 transcription factor re-
sulted in increased MT1-MMP gene expression by the
end of mechanical stimulation, which returned to constitu-
tive levels 2 h later. Elevated MT1-MMP protein levels
were observed as early as 1 h post-stimulation returning
to baseline by 6 h. The mechanosensitivity of this protease
was conﬁrmed using an MT1-MMP promoter reporter con-
struct. Inhibition of ERK1/2 activation (by U1026) or Egr-1
binding (by ODN) during mechanical stimulation prevented
the increase in MT1-MMP gene expression conﬁrming the
involvement of the ERK-Egr-1 signaling pathway in tran-
scriptional regulation. In contrast to the ﬁndings of the cur-
rent study, a previous report suggested that MT1-MMP
(MMP-14) is not mechanosensitive31. However, the study
by Fehrenbacher et al.31 used cyclic compression of 3 or
6 MPa at 0.1 Hz for 10 min and porcine cartilage explants.
The differences in cell source (pig vs bovine), loading re-
gimes and the use of mature explants rather than in vitro
grown chondrocytes with a small amount of pericellular ma-
trix (less tissue than explants) may explain the differences
seen in the response of MT1-MMP to mechanical stimula-
tion. Furthermore, MT1-MMP has been shown to be mecha-
nosensitive, either positively or negatively, in other cell
1307Osteoarthritis and Cartilage Vol. 15, No. 11types and is responsive to compressive or shear forces. Rat
endothelial cells exposed to cyclic strain (1 Hz for 24 h)
showed increased MT1-MMP expression12. In a rabbit
model of ﬂow-induced arterial enlargement, MT1-MMP
was upregulated in response to high ﬂow rates and shear
stresses and contributed to arterial remodeling32. In an os-
teoblast cell line, static compression (1 g/cm2) induced
bone formation and this correlated with increased MT1-
MMP expression33,34. Bovine smooth muscle cells, in con-
trast, downregulate MT1-MMP expression in the presence
of shear stress35.
The entire signaling mechanism regulating MT1-MMP ex-
pression has not been fully elucidated and furthermore,
where studied it seems to vary among different cell types.
In the current study, we demonstrated a critical role for
ERK1/2 in regulating MT1-MMP gene levels. It was not sur-
prising that ERK1/2 was involved for several reasons.
Firstly, we and others have shown that this MAPK is mecha-
nosensitive10,36e39. Secondly ERK1/2 activation has been
shown to increase MT1-MMP expression22,40,41. However,
in those studies the stimuli used were not mechanical
stimulation. Interestingly, ERK1/2 does not always have
a positive regulatory effect in all cell types. For example,
transforming growth factor-beta stimulation of MT1-MMP
expression in cancer cells does not occur through ERK1/
242 and inhibition of ERK1/2 activation in 3RY1 rat cells
does not affect MT1-MMP levels43. Thus, the role of
ERK1/2 in regulating MT1-MMP expression is complex
and may be inﬂuenced by the stimulus and/or cell type.
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Fig. 6. Inhibition of Egr-1 and the effect on MT1-MMP. (A) EMSA of
DNA binding activity to an MT1-MMP promoter sequence in nuclear
proteins extracted from chondrocytes which had undergone cyclic
compression in the presence of vehicle alone, phosphorothioated
MT1-MMP ODN or phosphorothioated mutant MT1-MMP ODN.
The proteins were obtained immediately after mechanical stimula-
tion (at time 0). Control cells were treated similarly but did not un-
dergo mechanical stimulation (US). (B) Total RNA was extracted
15 min after mechanical stimulation ended. Relative RT-PCR anal-
ysis of MT1-MMP gene expression in cells treated with vehicle
alone, phosphorothioated MT1-MMP ODN or phosphorothioated
mutant MT1-MMP ODN. Gene expression was normalized to 18S
rRNA and expressed as the fold change of stimulated (S) to unsti-
mulated (US) samples. * indicates a signiﬁcant difference between
groups, P< 0.05.Vehicle U0126 
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Fig. 7. ERK1/2 activation during cyclic compression of chondro-
cytes. (A) Chondrocytes were cyclically compressed and tissues
were harvested after 5 min (25), 15 min (15) or 30 min (0) of me-
chanical stimulation. Total proteins were extracted and examined
by immunoblotting with antibodies reactive to total or phosphory-
lated ERK1/2 and semi-quantiﬁed by densitometry. Representative
western blots showing phosphorylated ERK1/2 and total ERK1/2
levels in unstimulated (US) and stimulated (S) chondrocytes. (B)
Fold change in phospho-ERK1/2 protein expression over time in
the presence of stimulation. The results of four experiments were
combined and the levels of p-ERK1/2 were expressed as mean
S.E.M. * indicates a signiﬁcant difference from corresponding US
control. (C) EMSA of DNA binding activity to an MT1-MMP pro-
moter sequence using nuclear proteins from mechanically S chon-
drocytes treated with U0126 or vehicle alone and extracted
immediately after cyclic compression. Control cells were treated
similarly but did not undergo mechanical stimulation (US). (D) Total
RNA was extracted 15 min after mechanical stimulation ended. RT-
PCR analysis of MT1-MMP gene expression in chondrocytes
treated with U0126 or vehicle alone. Gene expression was normal-
ized to 18S rRNA and expressed as the fold change of S to US
samples. ** indicates a signiﬁcant difference between groups,
P< 0.05.
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sion increased Egr-1 gene and protein expression. This is
in keeping with work by others that demonstrated that
Egr-1 is sensitive to mechanical stimulation in chondro-
cytes12,30,44 as well as in other cells such as osteoblasts
and endothelial cells45e47. Egr-1 has been implicated in
regulating MT1-MMP transcription in glomerular mesangial
cells48 and endothelial cells21 and this regulatory pathway
can now be extended to chondrocytes. In addition, we
were able to demonstrate that Egr-1 binding was regulated
by ERK1/2 activation as inhibition of ERK1/2 phosphoryla-
tion by U1026, an MEK1/2 inhibitor, prevented the induction
of MT1-MMP.
The promoter region for MT1-MMP contains overlapping
consensus sequences for the binding sites of the Egr-1
and the Sp1 transcription factors. It has been suggested
that competition between these two transcription factors
for binding determines whether the gene for MT1-MMP is
activated (when Egr-1 is bound)12 or inhibited (when Sp1
is bound)49. Displacement of Egr-1 by Sp1 only occurs after
phosphorylation at several different sites on Sp1, which
increases its afﬁnity for DNA binding. Sp1 is mechano-
sensitive as shear stress increased Sp1 activation in
endothelial cells and inhibited MT1-MMP expression49.
Our ﬁndings would explain why MT1-MMP transcription
was upregulated by cyclic compression as at the time points
investigated increased DNA binding activity at the MT1-
MMP promoter was through Egr-1. We did not observe
any change in Sp1 binding activity by EMSA nor a change
in Sp1 gene expression by RT-PCR (data not shown) sug-
gesting it was not mechanosensitive under these conditions
and unlikely to play a major role in mediating chondrocyte
responsiveness to short-term cyclic compression. However,
a small decrease in Egr-1 DNA binding activity to the MT1-
MMP promoter sequence was observed by EMSA in the
presence of Sp1 speciﬁc oligonucleotides [Fig. 4(B)] sug-
gesting that there might be some Sp1 binding activity occur-
ring. It is possible that the small amount of Sp1 binding
contributes to regulating the amount of MT1-MMP upregula-
tion that results with mechanical stimulation. Alternatively,
in immunoprecipitation studies it was shown that Egr-1
can physically interact with Sp150. Formation of an Sp1/
Egr-1 complex could result in decreased availability of
free Egr-1 and so the decreased binding demonstrated by
EMSA may be a non-speciﬁc effect.
It is not clear why Egr-1 protein expression is lower in the
stimulated cells compared to the non-stimulated cells by 6 h
[Fig. 5(B)]. At this time point Egr-1 could be having effects
other than regulating MT1-MMP. In human chondrocytes,
induction of Egr-1 by interleukin-1b resulted in repression
of transcriptional activity of type II collagen51. Type II colla-
gen expression, one of the main constituents of articular
cartilage matrix is upregulated when Sp1 is bound, or in-
hibited when Egr-1 is bound and displacement of the
Egr-1 protein by the Sp1 transcription factor reversed this
inhibition51. Therefore, the decreased protein levels of
Egr-1, seen by 6 h [Fig. 5(B)] may lead to the increased colla-
gen production by chondrocytes observed by 24 hafter cyclic
compression. Additional studies, however, will be required to
conﬁrm this.
As MT1-MMP is a membrane bound protease it may be
responsible for pericellular degradation52,53 as has been
shown for other 3D culture systems54,55. Rapid changes
in this protease are not surprising as MT1-MMP exists in
a pool within the cell allowing for rapid transport to the cell
membrane56. In a previous study, we have shown that
matrix degradation occurs after application of cycliccompression by demonstrating an increase in the amount
of newly synthesized collagen and proteoglycans released
into the media10. This increase can be detected as early
as 4 h (data not shown) and could be due to the increased
MT1-MMP protein levels. The inﬂuence of these degrada-
tion products on the forming cartilage tissue may be signif-
icant as highlighted recently57. It may be that the loss of cell
to matrix contact through increased pericellular degradation
is a signal for the anabolic activity that occurs after the initial
catabolic events. Interestingly, a recent study has demon-
strated that collagen fragments can induce induction of
MMP-13 by chondrocytes58 and would explain the in-
creased MMP-13 which we observed in our previous study.
Alternatively, the release of growth factors or cytokines
bound to collagen or proteoglycans through degradation
of the matrix may also be a cue to stimulate chondrocytes
to synthesize more ECM and represents an area of future
studies.
In summary, this study shows that cyclic compression of
chondrocytes that are forming cartilage tissue in vitro in-
creases MT1-MMP gene and protein levels and, that the
mechanosensitive induction of MT1-MMP is regulated by
ERK1/2 and Egr-1, events which occur during and immedi-
ately following mechanical stimulation. This catabolic event
is likely part of the remodeling process. Understanding the
mechanisms that lead to improved tissue formation is criti-
cal to both developing better tissue engineered cartilage
but also to delineate conditions that can be used to enhance
cartilage regeneration in vivo.
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